SG11201900665VA - Cannabis composition - Google Patents
Cannabis compositionInfo
- Publication number
- SG11201900665VA SG11201900665VA SG11201900665VA SG11201900665VA SG11201900665VA SG 11201900665V A SG11201900665V A SG 11201900665VA SG 11201900665V A SG11201900665V A SG 11201900665VA SG 11201900665V A SG11201900665V A SG 11201900665VA SG 11201900665V A SG11201900665V A SG 11201900665VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- bay
- western australia
- perth
- pct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662370304P | 2016-08-03 | 2016-08-03 | |
| PCT/AU2017/050814 WO2018023163A1 (en) | 2016-08-03 | 2017-08-03 | Cannabis composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201900665VA true SG11201900665VA (en) | 2019-02-27 |
Family
ID=61072172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201900665VA SG11201900665VA (en) | 2016-08-03 | 2017-08-03 | Cannabis composition |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11779562B2 (https=) |
| EP (1) | EP3493798A4 (https=) |
| JP (1) | JP2019523283A (https=) |
| KR (2) | KR20190035791A (https=) |
| CN (1) | CN109843287A (https=) |
| AU (4) | AU2017307643B2 (https=) |
| BR (1) | BR112019001852A2 (https=) |
| CA (1) | CA3031810A1 (https=) |
| CL (1) | CL2019000270A1 (https=) |
| CO (1) | CO2019001044A2 (https=) |
| IL (2) | IL296008B2 (https=) |
| MX (1) | MX386620B (https=) |
| PE (1) | PE20200726A1 (https=) |
| SG (1) | SG11201900665VA (https=) |
| WO (1) | WO2018023163A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3031810A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| JP2019526541A (ja) | 2016-08-03 | 2019-09-19 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 大麻組成物 |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| NZ757591A (en) * | 2017-03-30 | 2026-03-27 | Ojai Energetics Pbc | Methods and compositions for enhancing health |
| AU2018100837B4 (en) * | 2017-06-19 | 2019-02-21 | Zelira Therapeutics Operations Pty Ltd | Sleep Disorder Compositions and Treatments Thereof |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| WO2019173242A1 (en) * | 2018-03-04 | 2019-09-12 | Cmg Partners, Inc. | Enhanced smokable cannabis-based therapeutic product for treatment of sleep disorders and chronic pain and method for making same |
| US20210251949A1 (en) * | 2018-06-15 | 2021-08-19 | California Cannabinoids | Compositions and Methods for Treatment of Narcolepsy and Related Disorders |
| CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| US20220160648A1 (en) * | 2019-02-13 | 2022-05-26 | Inspired Health Products, LLC | Composition Comprising Hydrolyzed Collagen and Cannabidiol and Use Thereof |
| NL2022616B1 (en) | 2019-02-21 | 2020-09-18 | Patrick Alexander Unger | Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia |
| US11554098B2 (en) | 2019-05-03 | 2023-01-17 | HFL Partners, LLC | Compositions comprising molecularly separated cannabinoids and terpene blends and methods of producing |
| CN118161552A (zh) * | 2019-12-19 | 2024-06-11 | 史蒂文·罗斯斯坦 | 富含多酚化合物的提取物以及相关方法 |
| US11000818B1 (en) * | 2019-12-27 | 2021-05-11 | Cresco Labs Llc | Post processing method for cannabis oil |
| IT202000017137A1 (it) * | 2020-07-15 | 2022-01-15 | Linnea Sa | Estratti di cannabis sativa e loro usi |
| DK181329B1 (en) * | 2021-05-04 | 2023-08-16 | Cs Medica As | Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition |
| US20230000935A1 (en) * | 2021-07-03 | 2023-01-05 | Joseph Anthony Bidwell | Extract Infused Cannabis Flower, Natural preservation of Cannabis Flower and the method therefor |
| US20250144122A1 (en) * | 2023-11-06 | 2025-05-08 | Roberto Colon-Cruz | Scent-Changing Ointment & Method of Making The Same |
| WO2026010279A1 (ko) * | 2024-07-01 | 2026-01-08 | 피비엘바이오랩 주식회사 | 신규 유산균 및 이의 용도 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2400319B (en) | 2001-05-04 | 2005-06-08 | Gw Pharma Ltd | Cannabinoid-rich extracts |
| JP4411117B2 (ja) * | 2004-03-25 | 2010-02-10 | エスエス製薬株式会社 | 睡眠改善医薬組成物 |
| GB2418612A (en) | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
| JP2007246428A (ja) * | 2006-03-15 | 2007-09-27 | Nature Technology Inc | 植物精油成分を有効成分とする経皮吸収型睡眠覚醒用医薬組成物、その組成物を含有する経皮吸収型睡眠覚醒用医薬製剤、及びこれらの製造方法 |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| KR20110120153A (ko) * | 2010-04-28 | 2011-11-03 | 고려대학교 산학협력단 | 리모넨을 함유하는 아데노신 Ａ2ａ 수용체 작용제 |
| GB2495118B (en) | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| GB2496688B (en) | 2011-11-21 | 2016-06-29 | Gw Pharma Ltd | Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases |
| AU2013257322A1 (en) | 2012-05-03 | 2014-11-20 | Echo Pharmaceuticals B.V. | Cannabis plant isolate comprising delta9-tetrahydrocannabinol and a method for preparing such an isolate |
| US20150313868A1 (en) * | 2012-12-18 | 2015-11-05 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
| US10792318B2 (en) | 2013-03-14 | 2020-10-06 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
| US9095554B2 (en) * | 2013-03-15 | 2015-08-04 | Biotech Institute LLC | Breeding, production, processing and use of specialty cannabis |
| US10265292B2 (en) | 2013-09-18 | 2019-04-23 | The Werc Shop, LLC | Terpene-based compositions, processes methodologies |
| LT3062606T (lt) * | 2013-10-29 | 2019-07-10 | Biotech Institute, Llc | Specializuotų kanapių selekcija, gamyba, perdirbimas ir panaudojimas |
| CA2929280A1 (en) | 2013-10-31 | 2015-05-14 | Full Spectrum Laboratories, Ltd. | Terpene and cannabinoid formulations |
| US10610512B2 (en) * | 2014-06-26 | 2020-04-07 | Island Breeze Systems Ca, Llc | MDI related products and methods of use |
| AU2015279612A1 (en) | 2014-06-27 | 2017-02-02 | Kenton L. Crowley | Buccal and sublingual cannabinoid formulations and method of making the same |
| CA2996626A1 (en) * | 2014-08-25 | 2016-03-03 | Janing Holding Aps | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
| CN107205960A (zh) | 2014-10-21 | 2017-09-26 | 联合大麻公司 | 大麻提取物及其制备和使用方法 |
| MX385464B (es) | 2014-12-12 | 2025-03-18 | Ojai Energetics Pbc | Composiciones microencapsuladas de cannabinoides |
| IL253664B (en) | 2015-01-31 | 2022-09-01 | Constance Therapeutics Inc | Production method for extracting oil from cannabis and preparations |
| BR112017018316A2 (pt) | 2015-02-27 | 2018-04-17 | Ebbu Llc | composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral |
| CA3031810A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| CA3031811A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| JP2019526541A (ja) | 2016-08-03 | 2019-09-19 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 大麻組成物 |
| AU2018100837B4 (en) | 2017-06-19 | 2019-02-21 | Zelira Therapeutics Operations Pty Ltd | Sleep Disorder Compositions and Treatments Thereof |
| SG11202002169TA (en) | 2017-09-15 | 2020-04-29 | Zelda Therapeutics Operations Pty Ltd | Composition and method for treating autism |
| AU2018100924A4 (en) | 2018-07-03 | 2018-08-09 | Zelira Therapeutics Operations Pty Ltd | Composition and method for treating pain |
| WO2021248207A1 (en) | 2020-06-12 | 2021-12-16 | Zelira Therapeutics Operations Pty Ltd | Composition and method for treating chronic pain |
| PE20240682A1 (es) | 2020-11-06 | 2024-04-10 | Zelira Therapeutics Operations Pty Ltd | Tecnologia de encapsulacion de cannabinoides |
-
2017
- 2017-08-03 CA CA3031810A patent/CA3031810A1/en active Pending
- 2017-08-03 KR KR1020197005589A patent/KR20190035791A/ko not_active Ceased
- 2017-08-03 EP EP17836097.0A patent/EP3493798A4/en active Pending
- 2017-08-03 AU AU2017307643A patent/AU2017307643B2/en not_active Ceased
- 2017-08-03 JP JP2019505171A patent/JP2019523283A/ja active Pending
- 2017-08-03 BR BR112019001852-2A patent/BR112019001852A2/pt not_active Application Discontinuation
- 2017-08-03 WO PCT/AU2017/050814 patent/WO2018023163A1/en not_active Ceased
- 2017-08-03 KR KR1020217002290A patent/KR20210013645A/ko not_active Ceased
- 2017-08-03 PE PE2019000330A patent/PE20200726A1/es unknown
- 2017-08-03 SG SG11201900665VA patent/SG11201900665VA/en unknown
- 2017-08-03 IL IL296008A patent/IL296008B2/en unknown
- 2017-08-03 IL IL264461A patent/IL264461B2/en unknown
- 2017-08-03 MX MX2019001285A patent/MX386620B/es unknown
- 2017-08-03 CN CN201780060688.4A patent/CN109843287A/zh active Pending
-
2018
- 2018-07-03 AU AU2018100923A patent/AU2018100923C4/en not_active Expired
-
2019
- 2019-01-31 CL CL2019000270A patent/CL2019000270A1/es unknown
- 2019-02-01 CO CONC2019/0001044A patent/CO2019001044A2/es unknown
- 2019-10-23 AU AU2019253841A patent/AU2019253841B2/en not_active Ceased
-
2021
- 2021-10-01 AU AU2021240297A patent/AU2021240297B2/en not_active Ceased
-
2022
- 2022-07-14 US US17/865,024 patent/US11779562B2/en active Active
-
2023
- 2023-09-01 US US18/460,012 patent/US12239628B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201900665VA (en) | Cannabis composition | |
| SG11201900596XA (en) | Cannabis composition | |
| SG11201900501RA (en) | Cannabis composition | |
| SG11201907427YA (en) | Engineered transferrin receptor binding polypeptides | |
| SG11201806322QA (en) | Maytansinoid derivatives, conjugates thereof, and methods of use | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201903359RA (en) | Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma | |
| SG11201906885TA (en) | Methods for the administration of certain vmat2 inhibitors | |
| SG11201804098TA (en) | Purinones as ubiquitin-specific protease 1 inhibitors | |
| SG11201900845YA (en) | Uses of il-13 antagonists for treating atopic dermatitis | |
| SG11201804118VA (en) | Compositions comprising bacterial strains | |
| SG11201804211YA (en) | Compositions comprising bacterial strains | |
| SG11201804368QA (en) | Storage assembly for prosthetic valve | |
| SG11201907435PA (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
| SG11201909561RA (en) | Octree-based convolutional neural network | |
| SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
| SG11201902949PA (en) | Pharmaceutical compositions and methods of treating cardiovascular diseases | |
| SG11201908092RA (en) | Anti-tigit antigen-binding proteins and methods of use thereof | |
| SG11201804589TA (en) | Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists | |
| SG11201900558RA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
| SG11201806127XA (en) | Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer |